Filing Details

Accession Number:
0001144204-15-009282
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-13 20:13:34
Reporting Period:
2015-02-12
Filing Date:
2015-02-13
Accepted Time:
2015-02-13 20:13:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563665 Harvard Apparatus Regenerative Technology Inc. HART Surgical & Medical Instruments & Apparatus (3841) 455210462
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449450 Thomas Mcnaughton C/O Harvard Apparatus Regenerative Tech
84 October Hill Road, Suite 11
Holliston MA 01746
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-12 10,500 $2.59 31,628 No 4 P Direct
Common Stock Acquisiton 2015-02-13 3,500 $2.91 35,128 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $2.52 to $2.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $2.81 to $2.95. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 30,523 shares of common stock held by the Reporting Person.
  4. Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 34,023 shares of common stock held by the Reporting Person.